Understanding your customers' reimbursement outlook is critical. The 2018 Medicare Reimbursement Report compiles all the information you need, packed with insights on Medicare's payment adjustments, quality programs, as well as key trends and issues. The report provides a policy outlook for all markets as well as detailed analyses and primer for the Medicare program as a whole.
Although the majority of healthcare providers will receive small payment
increases from Medicare in 2018, they continue to face an uncertain
reimbursement future. The Centers for Medicare & Medicaid Services (CMS)
is accelerating efforts to tie Medicare payment to quality and outcomes
across all provider settings, which will lead to continued shifts in
payment models. Specific provider segments including labs and physicians
have even more uncertainty as congressionally-mandated payment changes
have started to be implemented.
CMS has finalized payment updates to all markets, and the changes between final and proposed rules indicate a desire to alleviate administrative burdens and lower costs. However, not everyone is satisfied with the outcomes as each market has its own unique challenges. For instance, CMS's changes to the clinical laboratory fee schedule would save the government payer around $670 million, despite vocal concern from the lab industry that the agency is using incomplete data.
While policymakers continue to push initiatives that hold providers
accountable on quality and cost, the tumultuous effort to "repeal and
replace" the Affordable Care Act (ACA) further indicated a clear desire
by the new Republican administration and Congress to move away from a
healthcare status quo, and institute wholesale changes. After initially
failing, the House did pass a plan to repeal the ACA. However, the
Senate was not able to pass similar legislation despite repeated
attempts and various versions.
This prompted President Trump to sign an executive order that expanded
access to more loosely regulated health plans among other contentious
provisions. With other legislative priorities pressing, Congress chose
to put their health reform efforts on hold for 2017, but may look to
resume them in 2018. Regardless, cost and quality initiatives are very
bipartisan concepts and will remain in some form, irrespective of how
Congress chooses to handle any future ACA repeal efforts.
Key Topics Covered:
1. The Acute Care Market
2. The Physician Market
3. The Laboratory Market
4. The Post Acute Market
For more information about this report visit https://www.researchandmarkets.com/research/qv4p9c/medicare?w=4